[Research on the legal regulation of experimental medicine in China].
Zhonghua Yi Xue Za Zhi
; 103(18): 1367-1372, 2023 May 16.
Article
en Zh
| MEDLINE
| ID: mdl-37150688
The increasing number of clinical trials of new drugs in China has brought huge benefits to the society, but also implied huge risks. This is particularly evident in experimental medicine. Germany has achieved good results in regulating experimental medical behaviors through the model of legislative norms. China should learn from Germany's beneficial experience to promote the orderly development of experimental medical behavior in China. Specifically, the crime of illegal human experiment should be added to the criminal law; Adopt special legislation model to regulate experimental medical behavior; Establish a no fault medical liability system to share experimental medical risks;Absorb and learn from the relevant norms of the international community on human experiment.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Responsabilidad Legal
/
Investigación Biomédica
Límite:
Humans
País/Región como asunto:
Asia
/
Europa
Idioma:
Zh
Revista:
Zhonghua Yi Xue Za Zhi
Año:
2023
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
China